lotilaner FDA approval date

The FDA approved lotilaner on 24 Jul 2023.

FDA approval date
24 Jul 2023

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)NCT07443202TARSPhase 2Enrolling by invitation2026-12-31Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-07-24DaylotilanerFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217603", "applicant_as_listed_by_fda": "TARSUS", "brand_names": ["XDEMVY"], "active_ingredients": ["LOTILANER"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230724", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026